2D7 diabody bound to the α2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells-Reference-Cited by-同舟云学术

2D7 diabody bound to the α2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells

Published:2004-12 Issue:4 Volume:325 Page:1201-1209
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Kimura Naoki,Kawai Shigeto,Kinoshita Yasuko,Ishiguro Takahiro,Azuma Yumiko,Ozaki Shuji,Abe Masahiro,Sugimoto Masamichi,Hirata Yuichi,Orita Tetsuro,Okabe Hisafumi,Matsumoto Toshio,Tsuchiya Masayuki

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference25 articles.

1. Therapeutic anticancer antibodies;Murray;Expert Opin. Ther. Patents,2003

2. Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma;Ellis;J. Immunol.,1995

3. Monoclonal antibody-mediated tumor regression by induction of apoptosis;Trauth;Science,1989

4. The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin;Ghetie;Blood,1992

5. Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest;Ghetie;Blood,1994

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concise Review: Defining and Targeting Myeloma Stem Cell‐Like Cells;STEM CELLS;2014-04-17

2. Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma;European Journal of Haematology;2013-04-17

3. Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors;Leukemia;2012-03-20

4. Epithelial Membrane Protein-2 Is a Novel Therapeutic Target in Ovarian Cancer;Clinical Cancer Research;2010-07-28

5. VH/VL interface engineering to promote selective expression and inhibit conformational isomerization of thrombopoietin receptor agonist single-chain diabody;Protein Engineering Design and Selection;2010-06-24